The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
Table 4
Cardiovascular risk factors and outcomes.
Low TyG index (≤8.805, )
High TyG index (>8.805, )
value
GMD (-),
GMD (+),
GMD (-),
GMD (+),
, (%)
43 (25.6)
17 (33.3)
57 (71.3)
122 (87.8)
<0.001
, (%)
47 (28.0)
24 (47.1)
24 (30.0)
70 (50.4)
<0.001
Multivessel disease, (%)
55 (32.7)
27 (52.9)
59 (73.8)
119 (85.6)
<0.001
SYNTAX score
5.0 (3.0–8.0)
7.0 (5.0–13.0)
12.0 (8.0–17.0)
17.0 (12.0–25.0)
<0.001
GRACE score
87.0 (74.0–105.0)
105.0 (88.0–122.0)
105.0 (82.0–120.0)
113.0 (92.0–135.0)
<0.001
MetS, (%)
18 (10.7)
15 (29.4)
27 (33.8)
79 (56.8)
<0.001
MACEs, (%)
15 (8.9)
13 (25.5)
13 (16.3)
37 (26.6)
<0.001
Cardiac death, (%)
2 (1.2)
3 (5.9)
2 (2.5)
11 (7.9)
0.014
Nonfatal myocardial infarction, (%)
3 (1.8)
5 (9.8)
4 (5.0)
8 (5.8)
0.056
TVR, (%)
5 (3.0)
3 (5.9)
4 (5.0)
12 (8.6)
0.178
Congestive heart failure, (%)
4 (2.4)
1 (2.0)
2 (2.5)
3 (2.2)
1
Nonfatal stroke, (%)
1 (0.6)
1 (2.0)
1 (1.3)
3 (2.2)
0.488
Data are expressed as the median (IQR) or (%). Abbreviations: MACEs: major adverse cardiovascular events; TVR: target vessel revascularization; GMD: glucose metabolism disorder; MetS: metabolic syndrome; CRP: C-reactive protein; BNP: B type natriuretic peptide.
